Keytruda Approved in China for Esophageal Squamous Cell Carcinoma Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter Keytruda is now approved in China for three different types of cancer. Source: Devices & Diagnostics Letter You Might Also Like Genfit Ends Phase 3 Trial of NASH Drug Elanfibranor After Finding No Benefit July 22, 2020 TriNetX, Harvard Pilgrim Health Care Institute to Monitor COVID-19 Drug Usage May 21, 2020 Three More States Pursue Drug Price Controls February 21, 2020